Crossmark

The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia

Crossref DOI link: https://doi.org/10.1007/s10557-023-07455-y

Published Online: 2023-05-02

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Konečný, Lukáš

Hrubša, Marcel

Karlíčková, Jana

Carazo, Alejandro

Javorská, Lenka

Matoušová, Kateřina

Krčmová, Lenka Kujovská

Blaha, Vladimír

Bláha, Milan

Mladěnka, Přemysl https://orcid.org/0000-0002-6076-6900
Funding

Funding for this research was provided by:

Agentura Pro Zdravotnický Výzkum České Republiky (NU21J-02-00021)

Univerzita Karlova v Praze (SVV 260 549)

MH CZ - DRO (UHHK)

MH CZ - DRO (00179906)

Charles University
License Information

Text and Data Mining valid from 2023-05-02

Version of Record valid from 2023-05-02
More Information

Article History

Accepted: 18 April 2023

First Online: 2 May 2023

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Hospital in Hradec Králové (No. 202007 S01P from June 18th, 2020).

: Informed consent was obtained from all individual participants included in the study.

: The paper does not contain figures or other images with personal data.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below